Ozempic maker Novo Nordisk invests $4bn to expand US production; Pharma group plans plant in North Carolina to produce diabetes drug and weight-loss product WegovyBusiness live -- latest updates

Subjects

Subjects :

Novo Nordisk A/S
Ozempic (Medication)
Wegovy (Medication)
Drug therapy
Diet industry
Hypoglycemic agents
Diabetes therapy
Pharmaceutical industry
Weight loss -- Drug therapy
Semaglutide
Weight loss industry

Details

Language :

English

ISSN :

02613077

Database :

Gale General OneFile

Journal :

The Guardian (London, England)

Publication Type :

News

Accession number :

edsgcl.798919182